News about Drug Discovery & Development

Aurigene Rolls Out AI and ML Assisted Drug Discovery Platform

Aurigene Pharmaceutical Services Ltd., a subsidiary of Dr Reddy’s Laboratories, has launched Aurigene. AI, an innovative platform integrating artificial intelligence.

Drug Discovery & Development | 05/04/2024 | By Aishwarya |  1132

Asahi Kasei Medical and AW Technologies Sign Agreement for TrachFlush in Japan

AW Technologies is currently in the process of medical device registration of the TrachFlush in Japan, with market launch targeted in fiscal 2024.

Drug Discovery & Development | 03/04/2024 | By Manvi |  746

Teva UK and Closed Loop Medicine Collaborates to Advance Development of Personalised Medicines

Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.

Drug Discovery & Development | 26/03/2024 | By Manvi |  256

Aptamer Sciences Files IND Application for Phase 1 Clinical Trial of AST-201

Aptamer Sciences Inc. has filed for an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety

Drug Discovery & Development | 26/03/2024 | By Manvi |  1093

NeuExcell Therapeutics Hits New Milestone in Treatment of Malignant Glioma with NXL-004

NeuExcell Therapeutics has successfully given the dosing of the first patient with the first-in-class NeuroD1 gene therapy product NXL-004.

Drug Discovery & Development | 22/03/2024 | By Manvi |  477

Romaco Tecpharm Develops New ERS for Tablet Coaters

Romaco Tecpharm has announced the development of a new energy recovery system (ERS) for tablet coaters.

Drug Discovery & Development | 19/03/2024 | By Manvi |  256

New Marketing Code for Pharma Industry Issued by Indian Govt

The Department of Pharmaceuticals has issued a new code prohibiting pharma companies from offering gifts and travel facilities to healthcare professionals or their family members.

Drug Discovery & Development | 19/03/2024 | By Manvi |  807

Eureka Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS T-cell Therapy

This milestone represents one of the first engineered T-cell programs targeting solid tumors to reach Phase II.

Drug Discovery & Development | 18/03/2024 | By Manvi |  466

Biotheus Expanded Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates

Biotheus will grant Hansoh Pharma a license to use the proprietary anti-EGFR/cMet bispecific antibody PM1080/HS-20117 independently developed by Biotheus for the development of antibody-drug conjugates products (ADC Product).

Drug Discovery & Development | 16/03/2024 | By Manvi |  757

Epsilogen and Lonza Achieve Breakthrough in Cancer Treatment with MOv18 IgE Antibody

The companies have successfully completed the Good Manufacturing Practice (GMP) manufacturing of MOv18 IgE, Epsilogen’s leading IgE antibody drug candidate.

Drug Discovery & Development | 07/03/2024 | By Abha |  729